Publications

MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.
Cancer Cell 2017 Jun;31(6):755-770.e6
Department of Pediatrics, Section of Hematology/Oncology/BMT, University of Colorado, Denver/Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmacology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address:

Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
Cell Rep 2016 Mar 18;14(8):1953-65. Epub 2016 Feb 18.
Department of Pediatrics, Section of Pediatric Hematology/Oncology/Bone Marrow Transplantation, University of Colorado Denver, Aurora, CO 80045, USA; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO 80045, USA. Electronic address:

Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model.
Exp Hematol 2015 Nov 26;43(11):930-935.e6. Epub 2015 Jun 26.
Center for Cancer and Blood Disorders, Children's Hospital Colorado, and Department of Pediatrics, Section of Pediatric Hematology/Oncology/Bone Marrow Transplantation, University of Colorado Denver, 13123 East 16th Avenue, Aurora, CO 80045, USA.

Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer.
Nat Chem Biol 2013 Oct 25;9(10):643-50. Epub 2013 Aug 25.
1] Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Mapping cellular hierarchy by single-cell analysis of the cell surface repertoire.
Cell Stem Cell 2013 Oct 12;13(4):492-505. Epub 2013 Sep 12.
Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.

OF